Hamilton Thomas Edward
SEC CIK 1769848 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | Dir | 714.8K | $2.66M | — | 5 | 2021-06-30 | 2026-07-06 |
Most active insiders at LRMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | $25.00M | — |
| 2 | Hamilton Thomas Edward | Dir | $666.9K | — |
| 3 | THOMAS FRANK E | Dir | $25.0K | — |
| 4 | SHERMAN JEFFREY W | Dir | $25.0K | — |
| 5 | Shankar Gopi | Chief Development Off | — | — |
| 6 | Clayton Russell | Chief Medical Off | — | — |
| 7 | BEN-MAIMON CAROLE | Pres, CEO, Dir | — | — |
| 8 | Celano Michael | CFO | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-08 16:05 | 2026-07-06 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Dir | P - Purchase | $3.34 | +50.0K | 714.8K | +8% | +$166.9K | |
| 2026-03-02 | 2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Dir | P - Purchase | $5.00 | +100.0K | 664.8K | +18% | +$500.0K | |
| D | 2024-05-31 | 2024-02-16 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Dir | P - Purchase | $8.74 | +57.2K | 564.8K | +11% | +$500.0K |
| 2022-09-20 | 2022-09-16 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Dir | P - Purchase | $3.15 | +317.5K | 507.6K | +167% | +$1000.0K | |
| 2021-07-02 | 2021-06-30 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Dir | P - Purchase | $8.75 | +56.7K | 190.1K | +43% | +$496.2K |
Purchase Sale Sale after option exercise All abbreviations